{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:54:00Z","timestamp":1791921240402,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T00:00:00Z","timestamp":1621209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/OFIRG\/0070\/2018"],"award-info":[{"award-number":["NMRC\/OFIRG\/0070\/2018"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TRPM4 is a calcium-activated non-selective monovalent cation channel implicated in diseases such as stroke. Lack of potent and selective inhibitors remains a major challenge for studying TRPM4. Using a polypeptide from rat TRPM4, we have generated a polyclonal antibody M4P which could alleviate reperfusion injury in a rat model of stroke. Here, we aim to develop a monoclonal antibody that could block human TRPM4 channel. Two mouse monoclonal antibodies M4M and M4M1 were developed to target an extracellular epitope of human TRPM4. Immunohistochemistry and western blot were used to characterize the binding of these antibodies to human TRPM4. Potency of inhibition was compared using electrophysiological methods. We further evaluated the therapeutic potential on a rat model of middle cerebral artery occlusion. Both M4M and M4M1 could bind to human TRPM4 channel on the surface of live cells. Prolonged incubation with TRPM4 blocking antibody internalized surface TRPM4. Comparing to M4M1, M4M is more effective in blocking human TRPM4 channel. In human brain microvascular endothelial cells, M4M successfully inhibited TRPM4 current and ameliorated hypoxia-induced cell swelling. Using wild type rats, neither antibody demonstrated therapeutic potential on stroke. Human TRPM4 channel can be blocked by a monoclonal antibody M4M targeting a key antigenic sequence. For future clinical translation, the antibody needs to be humanized and a transgenic animal carrying human TRPM4 sequence is required for in vivo characterizing its therapeutic potential.<\/jats:p>","DOI":"10.1038\/s41598-021-89935-5","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T06:04:53Z","timestamp":1621231493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Development and characterization of a monoclonal antibody blocking human TRPM4 channel"],"prefix":"10.1038","volume":"11","author":[{"given":"See Wee","family":"Low","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Nilius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,17]]},"reference":[{"key":"89935_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/978-3-642-54215-2_18","volume":"222","author":"I Mathar","year":"2014","unstructured":"Mathar, I. et al. Trpm4. Handb. Exp. Pharmacol. 222, 461\u2013487. https:\/\/doi.org\/10.1007\/978-3-642-54215-2_18 (2014).","journal-title":"Handb. Exp. Pharmacol."},{"key":"89935_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00424-006-0088-z","volume":"453","author":"B Nilius","year":"2006","unstructured":"Nilius, B. & Vennekens, R. From cardiac cation channels to the molecular dissection of the transient receptor potential channel TRPM4. Pflugers Arch. 453, 313\u2013321. https:\/\/doi.org\/10.1007\/s00424-006-0088-z (2006).","journal-title":"Pflugers Arch."},{"key":"89935_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1113\/jphysiol.2005.088377","volume":"567","author":"B Nilius","year":"2005","unstructured":"Nilius, B. et al. Gating of TRP channels: A voltage connection?. J. Physiol. 567, 35\u201344. https:\/\/doi.org\/10.1113\/jphysiol.2005.088377 (2005).","journal-title":"J. Physiol."},{"key":"89935_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/sj.emboj.7600963","volume":"25","author":"B Nilius","year":"2006","unstructured":"Nilius, B. et al. The Ca2+-activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5-biphosphate. EMBO J. 25, 467\u2013478. https:\/\/doi.org\/10.1038\/sj.emboj.7600963 (2006).","journal-title":"EMBO J."},{"key":"89935_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ni1441","volume":"8","author":"R Vennekens","year":"2007","unstructured":"Vennekens, R. et al. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nat. Immunol. 8, 312\u2013320. https:\/\/doi.org\/10.1038\/ni1441 (2007).","journal-title":"Nat. Immunol."},{"key":"89935_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells7060062","author":"C Wang","year":"2018","unstructured":"Wang, C., Naruse, K. & Takahashi, K. Role of the TRPM4 channel in cardiovascular physiology and pathophysiology. Cells https:\/\/doi.org\/10.3390\/cells7060062 (2018).","journal-title":"Cells"},{"key":"89935_CR7","doi-asserted-by":"publisher","first-page":"e2006094","DOI":"10.1371\/journal.pbio.2006094","volume":"17","author":"MCD Picardo","year":"2019","unstructured":"Picardo, M. C. D. et al. Trpm4 ion channels in pre-Botzinger complex interneurons are essential for breathing motor pattern but not rhythm. PLoS Biol. 17, e2006094. https:\/\/doi.org\/10.1371\/journal.pbio.2006094 (2019).","journal-title":"PLoS Biol."},{"key":"89935_CR8","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1007\/s00429-018-1706-1","volume":"223","author":"M Bovet-Carmona","year":"2018","unstructured":"Bovet-Carmona, M. et al. Disentangling the role of TRPM4 in hippocampus-dependent plasticity and learning: An electrophysiological, behavioral and FMRI approach. Brain Struct. Funct. 223, 3557\u20133576. https:\/\/doi.org\/10.1007\/s00429-018-1706-1 (2018).","journal-title":"Brain Struct. Funct."},{"key":"89935_CR9","doi-asserted-by":"publisher","first-page":"F918","DOI":"10.1152\/ajprenal.00417.2012","volume":"304","author":"AC Smith","year":"2013","unstructured":"Smith, A. C. et al. TRPM4 channel: A new player in urinary bladder smooth muscle function in rats. Am. J. Physiol. Renal Physiol. 304, F918-929. https:\/\/doi.org\/10.1152\/ajprenal.00417.2012 (2013).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"89935_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1113\/JP271347","volume":"594","author":"T Hof","year":"2016","unstructured":"Hof, T. et al. TRPM4 non-selective cation channels influence action potentials in rabbit Purkinje fibres. J. Physiol. 594, 295\u2013306. https:\/\/doi.org\/10.1113\/JP271347 (2016).","journal-title":"J. Physiol."},{"key":"89935_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2019.04.012","volume":"454","author":"Y Gao","year":"2019","unstructured":"Gao, Y. & Liao, P. TRPM4 channel and cancer. Cancer Lett. 454, 66\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2019.04.012 (2019).","journal-title":"Cancer Lett."},{"key":"89935_CR12","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/nm.3015","volume":"18","author":"B Schattling","year":"2012","unstructured":"Schattling, B. et al. TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 18, 1805\u20131811. https:\/\/doi.org\/10.1038\/nm.3015 (2012).","journal-title":"Nat. Med."},{"key":"89935_CR13","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1002\/jnr.23529","volume":"93","author":"E Zhang","year":"2015","unstructured":"Zhang, E. & Liao, P. Brain transient receptor potential channels and stroke. J. Neurosci. Res. 93, 1165\u20131183. https:\/\/doi.org\/10.1002\/jnr.23529 (2015).","journal-title":"J. Neurosci. Res."},{"key":"89935_CR14","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1089\/neu.2017.5275","volume":"35","author":"KM Gorse","year":"2018","unstructured":"Gorse, K. M., Lantzy, M. K., Lee, E. D. & Lafrenaye, A. D. Transient receptor potential melastatin 4 induces astrocyte swelling but not death after diffuse traumatic brain injury. J. Neurotrauma 35, 1694\u20131704. https:\/\/doi.org\/10.1089\/neu.2017.5275 (2018).","journal-title":"J. Neurotrauma"},{"key":"89935_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nm.1899","volume":"15","author":"V Gerzanich","year":"2009","unstructured":"Gerzanich, V. et al. De novo expression of Trpm4 initiates secondary hemorrhage in spinal cord injury. Nat. Med. 15, 185\u2013191. https:\/\/doi.org\/10.1038\/nm.1899 (2009).","journal-title":"Nat. Med."},{"key":"89935_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/112_2018_13","volume":"176","author":"KY Loh","year":"2019","unstructured":"Loh, K. Y., Wang, Z. & Liao, P. Oncotic cell death in stroke. Rev. Physiol. Biochem. Pharmacol. 176, 37\u201364. https:\/\/doi.org\/10.1007\/112_2018_13 (2019).","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"89935_CR17","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/bph.13077","volume":"172","author":"SK Burris","year":"2015","unstructured":"Burris, S. K., Wang, Q., Bulley, S., Neeb, Z. P. & Jaggar, J. H. 9-Phenanthrol inhibits recombinant and arterial myocyte TMEM16A channels. Br. J. Pharmacol. 172, 2459\u20132468. https:\/\/doi.org\/10.1111\/bph.13077 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"89935_CR18","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2018-0049","author":"R Veress","year":"2018","unstructured":"Veress, R. et al. Transient receptor potential melastatin 4 channel inhibitor 9-phenanthrol inhibits K(+) but not Ca(2+) currents in canine ventricular myocytes. Can. J. Physiol. Pharmacol. https:\/\/doi.org\/10.1139\/cjpp-2018-0049 (2018).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"89935_CR19","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature04711","volume":"440","author":"CG Nichols","year":"2006","unstructured":"Nichols, C. G. KATP channels as molecular sensors of cellular metabolism. Nature 440, 470\u2013476. https:\/\/doi.org\/10.1038\/nature04711 (2006).","journal-title":"Nature"},{"key":"89935_CR20","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1074\/jbc.M112.428219","volume":"288","author":"SK Woo","year":"2013","unstructured":"Woo, S. K., Kwon, M. S., Ivanov, A., Gerzanich, V. & Simard, J. M. The sulfonylurea receptor 1 (Sur1)-transient receptor potential melastatin 4 (Trpm4) channel. J. Biol. Chem. 288, 3655\u20133667. https:\/\/doi.org\/10.1074\/jbc.M112.428219 (2013).","journal-title":"J. Biol. Chem."},{"key":"89935_CR21","doi-asserted-by":"publisher","first-page":"8746","DOI":"10.1074\/jbc.M111.336131","volume":"287","author":"M Sala-Rabanal","year":"2012","unstructured":"Sala-Rabanal, M., Wang, S. & Nichols, C. G. On potential interactions between non-selective cation channel TRPM4 and sulfonylurea receptor SUR1. J. Biol. Chem. 287, 8746\u20138756. https:\/\/doi.org\/10.1074\/jbc.M111.336131 (2012).","journal-title":"J. Biol. Chem."},{"key":"89935_CR22","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1111\/bph.14220","volume":"175","author":"LC Ozhathil","year":"2018","unstructured":"Ozhathil, L. C. et al. Identification of potent and selective small molecule inhibitors of the cation channel TRPM4. Br. J. Pharmacol. 175, 2504\u20132519. https:\/\/doi.org\/10.1111\/bph.14220 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"89935_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00424-013-1347-4","volume":"466","author":"KP Loh","year":"2014","unstructured":"Loh, K. P. et al. TRPM4 inhibition promotes angiogenesis after ischemic stroke. Pflugers Arch. 466, 563\u2013576. https:\/\/doi.org\/10.1007\/s00424-013-1347-4 (2014).","journal-title":"Pflugers Arch."},{"key":"89935_CR24","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1007\/s00424-019-02326-8","volume":"471","author":"B Chen","year":"2019","unstructured":"Chen, B. et al. TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke. Pflugers Arch. 471, 1455\u20131466. https:\/\/doi.org\/10.1007\/s00424-019-02326-8 (2019).","journal-title":"Pflugers Arch."},{"key":"89935_CR25","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.neuron.2019.02.002","volume":"102","author":"AL Zimmerman","year":"2019","unstructured":"Zimmerman, A. L. et al. Distinct modes of presynaptic inhibition of cutaneous afferents and their functions in behavior. Neuron 102, 420\u2013434. https:\/\/doi.org\/10.1016\/j.neuron.2019.02.002 (2019).","journal-title":"Neuron"},{"key":"89935_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12975-018-0621-3","volume":"10","author":"B Chen","year":"2019","unstructured":"Chen, B. et al. Non-invasive multimodality imaging directly shows TRPM4 inhibition ameliorates stroke reperfusion injury. Transl. Stroke Res. 10, 91\u2013103. https:\/\/doi.org\/10.1007\/s12975-018-0621-3 (2019).","journal-title":"Transl. Stroke Res."},{"key":"89935_CR27","doi-asserted-by":"publisher","first-page":"562584","DOI":"10.3389\/fcell.2020.562584","volume":"8","author":"S Wei","year":"2020","unstructured":"Wei, S. et al. Comparison of anti-oncotic effect of TRPM4 blocking antibody in neuron, astrocyte and vascular endothelial cell under hypoxia. Front. Cell Dev. Biol. 8, 562584. https:\/\/doi.org\/10.3389\/fcell.2020.562584 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"89935_CR28","doi-asserted-by":"publisher","first-page":"35247","DOI":"10.1038\/srep35247","volume":"6","author":"Z Hu","year":"2016","unstructured":"Hu, Z. et al. Aberrant splicing promotes proteasomal degradation of L-type CaV12 calcium channels by competitive binding for CaVbeta subunits in cardiac hypertrophy. Sci. Rep. 6, 35247. https:\/\/doi.org\/10.1038\/srep35247 (2016).","journal-title":"Sci. Rep."},{"key":"89935_CR29","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1096\/fj.201700346R","volume":"31","author":"F Zhang","year":"2017","unstructured":"Zhang, F. et al. The amyloid precursor protein modulates alpha2A-adrenergic receptor endocytosis and signaling through disrupting arrestin 3 recruitment. FASEB J. 31, 4434\u20134446. https:\/\/doi.org\/10.1096\/fj.201700346R (2017).","journal-title":"FASEB J."},{"key":"89935_CR30","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/STROKEAHA.108.541128","volume":"40","author":"M Fisher","year":"2009","unstructured":"Fisher, M. et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40, 2244\u20132250. https:\/\/doi.org\/10.1161\/STROKEAHA.108.541128 (2009).","journal-title":"Stroke"},{"key":"89935_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/mvre.1995.1052","volume":"50","author":"P He","year":"1995","unstructured":"He, P. & Curry, F. E. Measurement of membrane potential of endothelial cells in single perfused microvessels. Microvasc. Res. 50, 183\u2013198. https:\/\/doi.org\/10.1006\/mvre.1995.1052 (1995).","journal-title":"Microvasc. Res."},{"key":"89935_CR32","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1152\/physrev.2001.81.4.1415","volume":"81","author":"B Nilius","year":"2001","unstructured":"Nilius, B. & Droogmans, G. Ion channels and their functional role in vascular endothelium. Physiol. Rev. 81, 1415\u20131459. https:\/\/doi.org\/10.1152\/physrev.2001.81.4.1415 (2001).","journal-title":"Physiol. Rev."},{"key":"89935_CR33","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.1007\/s11095-015-1729-8","volume":"32","author":"S Xu","year":"2015","unstructured":"Xu, S. Internalization, trafficking, intracellular processing and actions of antibody-drug conjugates. Pharm. Res. 32, 3577\u20133583. https:\/\/doi.org\/10.1007\/s11095-015-1729-8 (2015).","journal-title":"Pharm. Res."},{"key":"89935_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12975-013-0281-2281","volume":"4","author":"CY Yu","year":"2013","unstructured":"Yu, C. Y., Ng, G. & Liao, P. Therapeutic antibodies in stroke. Transl. Stroke Res. 4, 477\u2013483. https:\/\/doi.org\/10.1007\/s12975-013-0281-2281 (2013).","journal-title":"Transl. Stroke Res."},{"key":"89935_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jpba.2009.07.013","volume":"51","author":"A Nechansky","year":"2010","unstructured":"Nechansky, A. HAHA\u2014Nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology. J. Pharm. Biomed. Anal. 51, 252\u2013254. https:\/\/doi.org\/10.1016\/j.jpba.2009.07.013 (2010).","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89935-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T03:25:24Z","timestamp":1670037924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89935-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89935"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89935-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,17]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10411"}}